Cargando…
Extralymphatic virus sanctuaries as a consequence of potent T-cell activation
T helper cells can support the functions of CD8(+) T cells against persistently infecting viruses such as murine lymphocytic choriomeningitis virus (LCMV), cytomegalovirus, hepatitis C virus and HIV. These viruses often resist complete elimination and remain detectable at sanctuary sites, such as th...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096094/ https://www.ncbi.nlm.nih.gov/pubmed/17982463 http://dx.doi.org/10.1038/nm1670 |
_version_ | 1783510750651744256 |
---|---|
author | Recher, Mike Lang, Karl S Navarini, Alexander Hunziker, Lukas Lang, Philipp A Fink, Katja Freigang, Stefan Georgiev, Panco Hangartner, Lars Zellweger, Raphael Bergthaler, Andreas Hegazy, Ahmed N Eschli, Bruno Theocharides, Alexandre Jeker, Lukas T Merkler, Doron Odermatt, Bernhard Hersberger, Martin Hengartner, Hans Zinkernagel, Rolf M |
author_facet | Recher, Mike Lang, Karl S Navarini, Alexander Hunziker, Lukas Lang, Philipp A Fink, Katja Freigang, Stefan Georgiev, Panco Hangartner, Lars Zellweger, Raphael Bergthaler, Andreas Hegazy, Ahmed N Eschli, Bruno Theocharides, Alexandre Jeker, Lukas T Merkler, Doron Odermatt, Bernhard Hersberger, Martin Hengartner, Hans Zinkernagel, Rolf M |
author_sort | Recher, Mike |
collection | PubMed |
description | T helper cells can support the functions of CD8(+) T cells against persistently infecting viruses such as murine lymphocytic choriomeningitis virus (LCMV), cytomegalovirus, hepatitis C virus and HIV. These viruses often resist complete elimination and remain detectable at sanctuary sites, such as the kidneys and other extralymphatic organs. The mechanisms underlying this persistence are not well understood. Here we show that mice with potent virus-specific T-cell responses have reduced levels and delayed formation of neutralizing antibodies, and these mice fail to clear LCMV from extralymphatic epithelia. Transfer of virus-specific B cells but not virus-specific T cells augmented virus clearance from persistent sites. Virus elimination from the kidneys was associated with the formation of IgG deposits in the interstitial space, presumably from kidney-infiltrating B cells. CD8(+) T cells in the kidneys of mice that did not clear virus from this site were activated but showed evidence of exhaustion. Thus, we conclude that in this model of infection, site-specific virus persistence develops as a consequence of potent immune activation coupled with reductions in virus-specific neutralizing antibodies. Our results suggest that sanctuary-site formation depends both on organ anatomy and on the induction of different adaptive immune effector mechanisms. Boosting T-cell responses alone may not reduce virus persistence. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nm1670) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7096094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-70960942020-03-26 Extralymphatic virus sanctuaries as a consequence of potent T-cell activation Recher, Mike Lang, Karl S Navarini, Alexander Hunziker, Lukas Lang, Philipp A Fink, Katja Freigang, Stefan Georgiev, Panco Hangartner, Lars Zellweger, Raphael Bergthaler, Andreas Hegazy, Ahmed N Eschli, Bruno Theocharides, Alexandre Jeker, Lukas T Merkler, Doron Odermatt, Bernhard Hersberger, Martin Hengartner, Hans Zinkernagel, Rolf M Nat Med Article T helper cells can support the functions of CD8(+) T cells against persistently infecting viruses such as murine lymphocytic choriomeningitis virus (LCMV), cytomegalovirus, hepatitis C virus and HIV. These viruses often resist complete elimination and remain detectable at sanctuary sites, such as the kidneys and other extralymphatic organs. The mechanisms underlying this persistence are not well understood. Here we show that mice with potent virus-specific T-cell responses have reduced levels and delayed formation of neutralizing antibodies, and these mice fail to clear LCMV from extralymphatic epithelia. Transfer of virus-specific B cells but not virus-specific T cells augmented virus clearance from persistent sites. Virus elimination from the kidneys was associated with the formation of IgG deposits in the interstitial space, presumably from kidney-infiltrating B cells. CD8(+) T cells in the kidneys of mice that did not clear virus from this site were activated but showed evidence of exhaustion. Thus, we conclude that in this model of infection, site-specific virus persistence develops as a consequence of potent immune activation coupled with reductions in virus-specific neutralizing antibodies. Our results suggest that sanctuary-site formation depends both on organ anatomy and on the induction of different adaptive immune effector mechanisms. Boosting T-cell responses alone may not reduce virus persistence. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nm1670) contains supplementary material, which is available to authorized users. Nature Publishing Group US 2007-11-04 2007 /pmc/articles/PMC7096094/ /pubmed/17982463 http://dx.doi.org/10.1038/nm1670 Text en © Nature Publishing Group 2007 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Recher, Mike Lang, Karl S Navarini, Alexander Hunziker, Lukas Lang, Philipp A Fink, Katja Freigang, Stefan Georgiev, Panco Hangartner, Lars Zellweger, Raphael Bergthaler, Andreas Hegazy, Ahmed N Eschli, Bruno Theocharides, Alexandre Jeker, Lukas T Merkler, Doron Odermatt, Bernhard Hersberger, Martin Hengartner, Hans Zinkernagel, Rolf M Extralymphatic virus sanctuaries as a consequence of potent T-cell activation |
title | Extralymphatic virus sanctuaries as a consequence of potent T-cell activation |
title_full | Extralymphatic virus sanctuaries as a consequence of potent T-cell activation |
title_fullStr | Extralymphatic virus sanctuaries as a consequence of potent T-cell activation |
title_full_unstemmed | Extralymphatic virus sanctuaries as a consequence of potent T-cell activation |
title_short | Extralymphatic virus sanctuaries as a consequence of potent T-cell activation |
title_sort | extralymphatic virus sanctuaries as a consequence of potent t-cell activation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096094/ https://www.ncbi.nlm.nih.gov/pubmed/17982463 http://dx.doi.org/10.1038/nm1670 |
work_keys_str_mv | AT rechermike extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT langkarls extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT navarinialexander extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT hunzikerlukas extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT langphilippa extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT finkkatja extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT freigangstefan extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT georgievpanco extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT hangartnerlars extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT zellwegerraphael extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT bergthalerandreas extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT hegazyahmedn extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT eschlibruno extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT theocharidesalexandre extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT jekerlukast extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT merklerdoron extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT odermattbernhard extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT hersbergermartin extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT hengartnerhans extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation AT zinkernagelrolfm extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation |